Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Asymchem Laboratories (Tianjin) Co., Ltd.
  6. Summary
    002821   CNE100002BZ6

ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.

(002821)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/12/2022 01/13/2022 01/14/2022 01/17/2022 01/18/2022 Date
359.32 357.17 349.53 370.77 378.8 Last
3597976 2881984 1965240 3119108 3236519 Volume
+3.55% -0.60% -2.14% +6.08% +2.17% Change
Estimated financial data (e)
Sales 2021 4 339 M 683 M 683 M
Net income 2021 991 M 156 M 156 M
Net cash position 2021 9 022 M 1 420 M 1 420 M
P/E ratio 2021 93,3x
Yield 2021 0,20%
Sales 2022 6 904 M 1 087 M 1 087 M
Net income 2022 1 597 M 251 M 251 M
Net cash position 2022 6 675 M 1 051 M 1 051 M
P/E ratio 2022 58,2x
Yield 2022 0,40%
Capitalization 97 441 M 15 348 M 15 340 M
EV / Sales 2021 20,4x
EV / Sales 2022 13,1x
Nbr of Employees 5 477
Free-Float 60,6%
More Financials
Company
Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is... 
Sector
Pharmaceuticals
Calendar
04/01Earnings Release
More about the company
Ratings of Asymchem Laboratories (Tianjin) Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
01/11AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK i..
CI
2021Hong Kong Stocks Snap Three-Day Winning Streak; Newcomers Fail to Book Gains in Trading..
MT
2021Asymchem Laboratories Shares Open Flat, Continues Streak of Lackluster Hong Kong Debuta..
MT
2021Asymchem Laboratories Prices Hong Kong IPO at Midpoint of Guidance, Raising $878 Millio..
MT
2021Asymchem Laboratories to Raise $917 Million After Pricing Hong Kong IPO at Midpoint of ..
MT
2021Asymchem Laboratories Co., Ltd. has filed an IPO in the amount of HKD 7.550314 billion.
CI
2021Asymchem Laboratories Plans to Raise $968 Million in Hong Kong IPO
DJ
2021Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2021Asymchem Laboratories Co., Ltd. agreed to acquire Beijing Improve-Quality Technology Co..
CI
2021Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Ca..
CI
2021Asymchem Laboratories Tianjin Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
2021Asymchem Laboratories Co., Ltd. Announces Final Cash Dividend for 2020 on its A Shares,..
CI
2021Tianjin Yugen Medtech Development Co., Ltd. announced that it expects to receive CNY 10..
CI
2021China stocks slip as healthcare firms retreat; Hong Kong up
RE
2021Asymchem Laboratories Co., Ltd. Announces Dividend for 2020
CI
More news
News in other languages on ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
01/11AUM Biosciences identifie Asymchem comme le partenaire CDMO de choix pour son nouvel in..
2021Les actions de Hong Kong perdent leur série de trois jours de gains ; les nouveaux venu..
2021Asymchem Laboratories (Tianjin) Co., Ltd. annonce le dividende final en espèces pour 20..
2021Laboratoires Asymchem (Tianjin) Co., Ltd. annonce un dividende pour 2020
2021FC INTER : Zhang detta la linea, mercato all'insegna dell'austerity (CorSera)
More news
Chart ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Duration : Period :
Asymchem Laboratories (Tianjin) Co., Ltd. Technical Analysis Chart | 002821 | CNE100002BZ6 | MarketScreener
Technical analysis trends ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 378,80 CNY
Average target price 461,13 CNY
Spread / Average Target 21,7%
EPS Revisions
Managers and Directors
Hao Hong Chairman & General Manager
Da Zhang CFO, Director & Deputy General Manager
Rui Yang COO, Director & Deputy General Manager
Kun Zhang Independent Non-Executive Director
Qing Song Wang Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.-14.77%15 026
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.10%325 363
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
NOVO NORDISK A/S-15.01%223 075